Update on marine omega-3 fatty acids: Management of dyslipidemia and current omega-3 treatment options
Open Access
- 1 October 2013
- journal article
- review article
- Published by Elsevier BV in Atherosclerosis
- Vol. 230 (2), 381-389
- https://doi.org/10.1016/j.atherosclerosis.2013.07.041
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- α-Linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysisThe American Journal of Clinical Nutrition, 2012
- Efficacy and Safety of Eicosapentaenoic Acid Ethyl Ester (AMR101) Therapy in Statin-Treated Patients With Persistent High Triglycerides (from the ANCHOR Study)The American Journal of Cardiology, 2012
- n–3 Fatty Acids and Cardiovascular Outcomes in Patients with DysglycemiaThe New England Journal of Medicine, 2012
- Novel developments in omega-3 fatty acid-based strategiesCurrent Opinion in Lipidology, 2011
- OMEGA, a Randomized, Placebo-Controlled Trial to Test the Effect of Highly Purified Omega-3 Fatty Acids on Top of Modern Guideline-Adjusted Therapy After Myocardial InfarctionCirculation, 2010
- n–3 Fatty Acids and Cardiovascular Events after Myocardial InfarctionThe New England Journal of Medicine, 2010
- Fish Oil for the Treatment of Cardiovascular DiseaseCardiology in Review, 2010
- Effects of Combination Lipid Therapy in Type 2 Diabetes MellitusThe New England Journal of Medicine, 2010
- Effects of Prescription Omega-3-Acid Ethyl Esters on Non—High-Density Lipoprotein Cholesterol When Coadministered With Escalating Doses of AtorvastatinMayo Clinic Proceedings, 2010
- Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trialThe Lancet, 2008